Drugs Archives - Page 16 of 66 - 51��Ƶ Health News

March Medicaid Madness

Episode 287

March 2, 2023

President Joe Biden and Republicans in Congress spent last month sparring over whether to shield Medicare and Social Security from budget cuts — leading some to wonder if Medicaid was on the table instead. Biden and Democrats say no, but some Republicans seem eager to trim federal spending on the health program for Americans with low incomes. And ready or not, artificial intelligence is coming to medical care. Benefits, as well as unintended consequences, are likely. Alice Miranda Ollstein of Politico, Rachel Cohrs of STAT News, and Lauren Weber of The Washington Post join KHN’s chief Washington correspondent, Julie Rovner, to discuss these issues and more.

Listen Now

Eli Lilly Slashed Insulin Prices. This Starts a Race to the Bottom.

Eli Lilly's news that it plans to cut insulin costs for patients will help, not hinder, the recent efforts in California and by entrepreneurs such as Mark Cuban to offer lower-cost alternatives, drug pricing experts said.

By Bram Sable-Smith and Samantha Young

March 2, 2023

A photo shows a box containing an EpiPen.

After Capping Insulin Copays, Colorado Sets Its Sights on EpiPens

Colorado’s proposed legislation to cap the copay for the EpiPen is part of a nationwide trend as more states try to shield patients from skyrocketing drug prices.

By Helen Santoro

Feb. 27, 2023

Letters to the Editor

Readers and Tweeters Urgently Plea for a Proper ‘Role’ Call in the ER

KHN gives readers a chance to comment on a recent batch of stories.

Feb. 27, 2023

A photo shows a box of Mifepristone pills.

One Texas Judge Will Decide Fate of Abortion Pill Used by Millions of American Women

“What happens in Texas doesn't stay in Texas,” warns an abortion rights advocate bracing for a district judge’s ruling on whether the abortion pill mifepristone was properly authorized by the FDA. His decision could force the medication off the U.S. market.

By Sarah Varney

Feb. 24, 2023

A photo shows an older woman sitting in a chair and looking to the left.

A Bitter Battle Over the ‘Orphan Drug’ Program Leaves Patients’ Pocketbooks at Risk

Patients who depend upon special drugs to treat rare diseases are caught in the crossfire as drugmakers and the FDA battle over regulations that reward companies for developing treatments for relatively small pools of patients.

By Sarah Jane Tribble

Feb. 22, 2023

A photo shows Mark Cuban speaking into a microphone at a tech conference.

Mark Cuban Has Been Taking On the Drug Industry. But Which One?

The billionaire entrepreneur and NBA team owner is making waves with his new drug company. But his generics aren’t always the lowest-priced deal.

By Darius Tahir

Feb. 17, 2023

What the Health? From 51��Ƶ Health News

The Kids Are Not OK

Episode 285

Feb. 16, 2023

A new survey from the Centers for Disease Control and Prevention finds that teenagers, particularly girls, are reporting all-time high rates of violence and profound mental distress. Meanwhile, both sides in the abortion debate are anxiously waiting for a district court decision in Texas that could effectively revoke the FDA’s 22-year-old approval of the abortion pill mifepristone. Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN’s chief Washington correspondent, Julie Rovner, to discuss these issues and more.

Listen Now

An illustration of two hands holding phones as large chat bubbles pop out from each phone. The chat bubble on the left shows a voting ballot box and exclamation points. The bubble on the right shows an insulin vial with dollar signs.

Armed With Hashtags, These Activists Made Insulin Prices a Presidential Talking Point

Twitter has been a hotbed for the burgeoning insulin access movement and activism surrounding other medical conditions. For people with diabetes, the platform has helped propel concern about insulin prices into policy. Can it continue to win with hashtags?

By Bram Sable-Smith

Feb. 15, 2023

Postcard From a Philadelphia Neighborhood

As Opioids Mixed With Animal Tranquilizers Arrive in Kensington, So Do Alarming Health Challenges

The veterinary tranquilizer xylazine, the choice du jour of local drug dealers to cut fentanyl, leads to necrotic ulcers and leaves street medics and physicians confused about how best to deal with this wave of the opioid crisis.

By Courtenay Harris Bond

Feb. 15, 2023

A man with black cloth covering his right eye over his glasses sits on the edge of a couch and looks off-camera to his left.

Your Money or Your Life: Patient on $50,000-a-Week Cancer Drug Fears Leaving Behind Huge Medical Debt

When Medicare stops paying for a pricey drug that prolongs life, an Ohio man considers giving up treatment to spare his family enormous debt.

By Fred Schulte

Feb. 14, 2023

Three photos are shown side-by-side. From left to right are a photo of a covid vaccine; a photo of a covid rapid test; a photo of Paxlovid.

COVID-19

Era of ‘Free’ Covid Vaccines, Test Kits, and Treatments Is Ending. Who Will Pay the Tab Now?

Insurers, employers, and taxpayers will all be affected as drug manufacturers move these products to the commercial market.

By Julie Appleby

Feb. 10, 2023

What the Health? From 51��Ƶ Health News

A Health-Heavy State of the Union

Episode 284

Feb. 9, 2023

President Joe Biden’s 2023 State of the Union address leaned heavily on health care issues. Biden took a victory lap for recent accomplishments like capping prescription drug costs for seniors on Medicare. He also urged Congress to make permanent the boosted premium subsidies under the Affordable Care Act, and he sparred with Republicans on threats to cut Social Security and Medicare. Also this week, both sides in the abortion debate are bracing for a court decision out of Texas that could, at least temporarily, make the abortion pill mifepristone illegal nationwide. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Sarah Karlin-Smith of the Pink Sheet join KHN chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Kate Baicker of the University of Chicago about a possible middle ground in the effort to get universal health insurance coverage.

Listen Now

Centene Agrees to $215 Million Settlement With California for Alleged Medicaid Overbilling

The nation’s largest Medicaid insurer denies wrongdoing after the California attorney general’s office investigated it for inflating prescription drug costs.

By Samantha Young

Feb. 8, 2023

A photo shows Senator Bernie Sanders speaking into a microphone in front of the U.S. Capitol.

‘We Ain’t Gonna Get It’: Why Bernie Sanders Says His ‘Medicare for All’ Dream Must Wait

As he takes the reins of the Senate Health, Education, Labor & Pensions Committee, the independent from Vermont and implacable champion of “Medicare for All” maps out his strategy for negotiating with Republicans — and Big Pharma.

By Arthur Allen

Feb. 8, 2023

U.S. 100 bills strewn across a table with a gavel positioned downward to signify a court case

The Pill Club Reaches $18.3 Million Medicaid Fraud Settlement With California

The online women’s pharmacy agreed to pay $15 million to the state Department of Justice and $3.3 million to the Department of Insurance over claims it overbilled Medi-Cal.

By Don Thompson

Feb. 7, 2023

A photo shows Elizabeth Fisher Smith at home with her husband.

Decisions by CVS and Optum Panicked Thousands of Their Sickest Patients

Pharmacy closures by two of the biggest home infusion companies point to grave shortages and dangers for patients who require IV nutrition to survive.

By Arthur Allen

Feb. 7, 2023

An illustration shows 3D models of the RSV virus.

A Technicality Could Keep RSV Shots From Kids in Need

The Vaccines for Children program, which buys more than half the pediatric vaccines in the U.S., may not cover the RSV shot for babies because it’s not technically a vaccine.

By Arthur Allen

Feb. 6, 2023

Patients for Profit: How Private Equity Hijacked Health Care

Some Addiction Treatment Centers Turn Big Profits by Scaling Back Care

Private equity groups are cashing in on rising rates of alcohol and drug addiction in the U.S. But they aren’t necessarily investing in centers with the best treatment standards, and they often cut extra services.

By Renuka Rayasam and Blake Farmer, Nashville Public Radio

Jan. 31, 2023

What the Health? From 51��Ƶ Health News

Part II: The State of the Abortion Debate 50 Years After ‘Roe’

Episode 282

Jan. 27, 2023

In Part II of this special two-part episode, Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Sarah Varney of KHN join KHN chief Washington correspondent Julie Rovner to discuss how the abortion debate has evolved since the Supreme Court overturned the nationwide right to abortion in 2022, and what might be the flashpoints for 2023. Also, for extra credit, the panelists recommend their most memorable reproductive health stories from the last year.

Listen Now

51��Ƶ

Trump 2.0

Public Health

Audio Reports

Special Reports

51��Ƶ

Drugs